Fabry Disease Screening Score

Estimate likelihood of Fabry disease using neuropathic pain, acroparesthesias, angiokeratoma, cornea verticillata, and family history criteria.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Estimate likelihood of Fabry disease using neuropathic pain, acroparesthesias, angiokeratoma, cornea verticillata, and family history criteria

Each component has a specific meaning:

  • Neuropathic pain — The neuropathic pain recorded for the scenario being assessed.
  • Acroparesthesias — The acroparesthesias recorded for the scenario being assessed.
  • Angiokeratoma — The angiokeratoma recorded for the scenario being assessed.
  • Cornea verticillata — The cornea verticillata recorded for the scenario being assessed.
  • Family history criteria — The family history criteria recorded for the scenario being assessed.

Note: Interpret the fabry screening result against the thresholds and context described above.

How to Use

Enter the neuropathic pain, acroparesthesias, angiokeratoma, cornea verticillata, family history criteria for the scenario you are assessing. Estimate likelihood of Fabry disease using neuropathic pain, acroparesthesias, angiokeratoma, cornea verticillata, and family history criteria. Use the fabry screening result to inform your calculation.

Frequently Asked Questions